HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.

AbstractAIMS:
The calcineurin and nuclear factor of activated T cells (NFAT) pathway can mediate pro-hypertrophic signalling in the heart. Recently, it has been shown that dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) phosphorylates NFAT, which limits calcineurin/NFAT signal transduction in T cells and hypertrophy in cultured cardiomyocytes. The hypothesis tested in this study was that DYRK1A prevents calcineurin/NFAT-mediated cardiac hypertrophy in vivo.
METHODS AND RESULTS:
In cultured rat cardiomyocytes, adenovirus-mediated overexpression of DYRK1A antagonized calcineurin-mediated nuclear NFAT translocation and the phenylephrine-induced hypertrophic growth response. To test the ability of DYRK1A to reduce hypertrophic cardiac growth in vivo, we created tetracycline-repressible Dyrk1a transgenic mice to avoid the cardiac developmental defects associated with embryonic DYRK1A expression. However, in the mouse model, histological determination of myocyte diameter, heart weight/body weight ratio, and echocardiographic measurements revealed that myocardial expression of DYRK1A failed to reduce hypertrophy induced via aortic banding or co-expression of calcineurin. This discrepancy is explained, at least in part, by insufficient long-term inhibition of NFAT and the activation of DYRK1A-resistant maladaptive genes in vivo.
CONCLUSION:
Isolated augmentation of DYRK1A can be compensated for in vivo, and this may significantly limit anti-hypertrophic interventions aimed at enhancing DYRK1A activity.
AuthorsCornelia Grebe, Theda-Maria Klingebiel, Simon Philipp Grau, Karl Toischer, Michael Didié, Claudius Jacobshagen, Christian Dullin, Gerd Hasenfuss, Tim Seidler
JournalCardiovascular research (Cardiovasc Res) Vol. 90 Issue 3 Pg. 521-8 (Jun 01 2011) ISSN: 1755-3245 [Electronic] England
PMID21273244 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • NFATC Transcription Factors
  • Recombinant Proteins
  • Phenylephrine
  • Dyrk kinase
  • Protein-Tyrosine Kinases
  • Protein Serine-Threonine Kinases
  • Calcineurin
Topics
  • Animals
  • Calcineurin (metabolism)
  • Cardiomegaly (genetics, metabolism, pathology, prevention & control)
  • Cells, Cultured
  • Female
  • Gene Knockdown Techniques
  • Male
  • Mice
  • Mice, Transgenic
  • Myocytes, Cardiac (drug effects, metabolism, pathology)
  • NFATC Transcription Factors (genetics, metabolism)
  • Phenylephrine (pharmacology)
  • Pregnancy
  • Protein Serine-Threonine Kinases (antagonists & inhibitors, genetics, metabolism)
  • Protein-Tyrosine Kinases (antagonists & inhibitors, genetics, metabolism)
  • Rats
  • Recombinant Proteins (genetics, metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: